Seminars in Oncology
Volume 31, Issue 5 , Pages 605-617 , October 2004

Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism

  • Tracy Richmond McKnight

      Affiliations

    • Department of Radiology, University of California, San Francisco, CA, USA.
    • Corresponding Author InformationAddress reprint requests to Tracy Richmond McKnight, PhD, Center for Molecular and Functional Imaging, 185 Berry St, Ste 350, Department of Radiology, University of California, San Francisco, CA 94107.

References 

  1. Lieberman DM , Laske DW , Morrison PF , et al.   Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion . J Neurosurg . 1995;82:1021–1029
  2. Kunwar S . Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma (Presentation of interim findings from ongoing phase 1 studies) . Acta Neurochir . 2003;88(suppl):105–111
  3. Larson DA , Gutin PH , McDermott M , et al.   Gamma knife for glioma (Selection factors and survival) . Int J Radiat Oncol Biol Phys . 1996;36:1045–1053
  4. Pirzkall A , Mcknight T , Graves E , et al.   MR-spectroscopy guided target delineation for high grade gliomas . Int J Radiat Oncol Biol Phys . 2001;50:915–928
  5. Nelson SJ , Graves E , Pirzkall A , et al.   In vivo molecular imaging for planning radiation therapy of gliomas (An application of 1H MRSI) . J Magn Reson Imaging . 2002;16:464–476
  6. McKnight TR , Noworolski SM , Vigneron DB , et al.   An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma . J Magn Reson Imaging . 2001;13:167–177
  7. Negendank WG , Sauter R , Brown TR , et al.   Proton magnetic resonance spectroscopy in patients with glial tumors (A multicenter study) . J Neurosurg . 1996;84:449–458
  8. Preul MC , Caramanos Z , Collins DL , et al.   Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy . Nat Med . 1996;2:323–325
  9. Tate AR , Majos C , Moreno A , et al.   Automated classification of short echo time in in vivo 1H brain tumor spectra (A multicenter study) . Magn Reson Med . 2003;49:29–36
  10. Spielman DM , Pauly JM , Macovski A , et al.   Lipid-suppressed single- and multisection proton spectroscopic imaging of the human brain . J Magn Reson Imaging . 1992;2:253–262
  11. Star-Lack J , Nelson SJ , Kurhanewicz J , et al.   Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING) . Magn Reson Med . 1997;38:311–321
  12. Wald LL , Moyher SE , Day MR , et al.   Proton spectroscopic imaging of the human brain using phased array detectors . Magn Reson Med . 1995;34:440–445
  13. Tran TK , Vigneron DB , Sailasuta N , et al.   Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer . Magn Reson Med . 2000;43:23–33
  14. Nelson SJ . Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors . Magn Reson Med . 2001;46:228–239
  15. Hagberg G , Burlina AP , Mader I , et al.   In vivo proton MR spectroscopy of human gliomas (Definition of metabolic coordinates for multi-dimensional classification) . Magn Reson Med . 1995;34:242–252
  16. Yacoe ME , Sommer G , Peehl D . In vitro proton spectroscopy of normal and abnormal prostate . Magn Reson Med . 1991;19:429–438
  17. Schick F , Bongers H , Kurz S , et al.   Localized proton MR spectroscopy of citrate in vitro and of the human prostate in vivo at 1.5 T . Magn Reson Med . 1993;29:38–43
  18. Nurenberg P , Sartoni-D’Ambrosia G , Szczepaniak LS . Magnetic resonance spectroscopy of renal and other retroperitoneal tumors . Curr Opin Urol . 2002;12:375–380
  19. Vezzoli A , Gussoni M , Greco F , et al.   Effects of temperature and extracellular pH on metabolites (Kinetics of anaerobic metabolism in resting muscle by 31P- and 1H-NMR spectroscopy) . J Exp Biol . 2003;206:3043–3052
  20. Sharma U , Atri S , Sharma MC , et al.   Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD) (An in-vitro proton NMR spectroscopy study) . Magn Reson Imaging . 2003;21:145–153
  21. Krssak M , Petersen KF , Bergeron R , et al.   Intramuscular glycogen and intramyocellular lipid utilization during prolonged exercise and recovery in man (A 13C and 1H nuclear magnetic resonance spectroscopy study) . J Clin Endocrinol Metab . 2000;85:748–754
  22. Chu DZ , Yamanashi WS , Frazer J , et al.   Proton NMR of human breast tumors (Correlation with clinical prognostic parameters) . J Surg Oncol . 1987;36:1–4
  23. Gribbestad IS , Fjösne HE , Haugen OA , et al.   In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue . Anticancer Res . 1993;13:1973–1980
  24. Gribbestad IS , Singstad TE , Nilsen G , et al.   In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil . J Magn Reson Imaging . 1998;8:1191–1197
  25. Cheng LL , Chang IW , Smith BL , et al.   Evaluating human breast ductal carcinomas with high-resolution magic-angle spinning proton magnetic resonance spectroscopy . J Magn Reson . 1998;135:194–202
  26. Roebuck JR , Cecil KM , Schnall MD , et al.   Human breast lesions (Characterization with proton MR spectroscopy) . Radiology . 1998;209:269–275
  27. Cecil KM , Schnall MD , Siegelman ES , et al.   The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy . Breast Cancer Res Treat . 2001;68:45–54
  28. Katz-Brull R , Lavin PT , Lenkinski RE . Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions . J Natl Cancer Inst . 2002;94:1197–1203
  29. Salibi NM , Brown MA . Clinical MR Spectroscopy (First Principles) . New York, NY: Wiley-Liss; 1998; 220
  30. Ross BD . Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; myo-inositol and related metabolites . NMR Biomed . 1991;4:59–63
  31. Negendank W . Studies of human tumors by MRS (A review) . NMR Biomed . 1992;5:303–324
  32. Gill SS , Thomas DG , Van Bruggen N , et al.   Proton MR spectroscopy of intracranial tumours (In vivo and in vitro studies) . J Comput Assist Tomogr . 1990;14:497–504
  33. Nelson SJ , Vigneron DB , Dillon WP . Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI . NMR Biomed . 1999;12:123–138
  34. Nelson SJ , Vigneron DB , Star-Lack J , et al.   High spatial resolution and speed in MRSI . NMR Biomed . 1997;10:411–422
  35. Vigneron DB , Nelson SJ , Murphy-Boesch J , et al.   Chemical shift imaging of human brain (axial, sagittal, and coronal P-31 metabolite images) . Radiology . 1999;177:643–649
  36. Kimura T , Sako K , Gotoh T , et al.   In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement . NMR Biomed . 2001;14:339–349
  37. Dowling C , Bollen AW , Noworolski SM , et al.   Preoperative proton MR spectroscopic imaging of brain tumors (Correlation with histopathologic analysis of resection specimens) . Am J Neuroradiol . 2001;22:604–612
  38. Graves EE , Nelson SJ , Vigneron DB , et al.   A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas . Neurosurgery . 2000;46:319–326
  39. Bitsch A , Bruhn H , Vougioukas V , et al.   Inflammatory CNS demyelination (Histopathologic correlation with in vivo quantitative proton MR spectroscopy) . Am J Neuroradiol . 1999;20:1619–1627
  40. Falini A , Calabrese G , Origgi D , et al.   Proton magnetic resonance spectroscopy and intracranial tumours (clinical perspectives) . J Neurol . 1996;243:706–714
  41. Fulham MJ , Bizzi A , Dietz MJ , et al.   Mapping of brain tumor metabolites with proton MR spectroscopic imaging (Clinical relevance) . Radiology . 1992;185:675–686
  42. Peeling J , Sutherland G . High-resolution 1H NMR spectroscopy studies of extracts of human cerebral neoplasms . Magn Reson Med . 1992;24:123–136
  43. Usenius JP , Vainio P , Hernesniemi J , et al.   Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro . J Neurochem . 1994;63:1538–1543
  44. Podo F . Tumour phospholipid metabolism . NMR Biomed . 1999;12:413–439
  45. Nishizuka Y . Membrane phospholipid degradation and protein kinase C for cell signalling . Neurosci Res . 1992;15:3–5
  46. Sabatier J , Gilard V , Malet-Martino M , et al.   Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors . Invest Radiol . 1999;34:230–235
  47. Nafe R , Herminghaus S , Raab P , et al.   Correlation between preoperative magnetic resonance spectroscopic data on high grade gliomas and morphology of Ki-67-positive tumor cell nuclei . Anal Quant Cytol Histol . 2003;25:131–138
  48. Kankaanranta L , Hakkinen AM , Jaaskelainen J , et al.   Choline in Proton MR Spectroscopy Correlates With MIB-1 Proliferation Index in Gliomas . Denver, CO: International Society of Magnetic Resonance in Medicine; 2000;
  49. Shimizu H , Kumabe T , Shirane R , et al.   Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas . Am J Neuroradiol . 2001;21:659–665
  50. Gupta R , Cloughesy T , Sinha U , et al.   Glioma MRS, Diffusion MRI and Histology: Choline and ADC Correlate With Cell Density . St Louis, MO: Biannual Meeting of the International Society of Magnetic Resonance in Medicine, MR of Cancer Working Group; 1998;
  51. Burtscher IM , Skagerberg G , Geijer B , et al.   Proton MR spectroscopy and preoperative diagnostic accuracy (an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings) . Am J Neuroradiol . 2000;21:84–93
  52. Shino A , Nakasu S , Matsuda M , et al.   Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy . J Neurosurg . 1999;91:928–934
  53. Barbarella G , Ricci R , Pirini G , et al.   In vivo single voxel 1H MRS of glial brain tumors (Correlation with tissue histology and in vitro MRS) . Int J Oncol . 1998;12:461–468
  54. McKnight T , Vigneron D , Love T , et al.   Comparison of a Cho-NAA Index With the MIB-1 Proliferative Index and Cell Density of Tissue Samples From Grades II and III Glioma . Honolulu, HI: International Society of Magnetic Resonance Medicine; 2002;
  55. Geller E , Faerber EN , Legido A , et al.   Rasmussen encephalitis (Complementary role of multitechnique neuroimaging) . Am J Neuroradiol . 1998;19:445–449
  56. Brooks WM , Stidley CA , Petropoulos H , et al.   Metabolic and cognitive response to human traumatic brain injury (A quantitative proton magnetic resonance study) . J Neurotrauma . 2000;17:629–640
  57. Tartaglia MC , Narayanan S , De Stefano N , et al.   Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis . J Neurol . 2002;249:1382–1390
  58. Li X , Lu Y , Pirzkall A , et al.   Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients . J Magn Reson Imaging . 2002;16:229–237
  59. Usenius JP , Tuohimetsä S , Vainio P , et al.   Automated classification of human brain tumours by neural network analysis using in vivo 1H magnetic resonance spectroscopic metabolite phenotypes . Neuroreport . 1996;7:1597–1600
  60. Majos C , Alonso J , Aguilera C , et al.   Proton magnetic resonance spectroscopy ((1)H MRS) of human brain tumours (assessment of differences between tumour types and its applicability in brain tumour categorization) . Eur Radiol . 2003;13:582–591
  61. Meyerand ME , Pipas JM , Mamourian A , et al.   Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy . Am J Neuroradiol . 1999;20:117–123
  62. Howe FA , Barton SJ , Cudlip SA , et al.   Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy . Magn Reson Med . 2003;49:223–232
  63. Kugel H , Heindel W , Ernestus RI , et al.   Human brain tumors (Spectral patterns detected with localized H-1 MR spectroscopy) . Radiology . 1992;183:701–709
  64. Manton DJ , Lowry M , Blackband SJ , et al.   Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours . NMR Biomed . 1995;8:104–112
  65. Majos C , Alonso J , Aguilera C , et al.   Utility of proton MR spectroscopy in the diagnosis of radiologically atypical intracranial meningiomas . Neuroradiology . 2003;45:129–136
  66. Alger JR , Frank JA , Bizzi A , et al.   Metabolism of human gliomas (Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET) . Radiology . 1990;177:633–641
  67. Opstad KS , Provencher SW , Bell BA , et al.   Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS . Magn Reson Med . 2003;49:632–637
  68. Usenius JP , Kauppinen RA , Vainio PA , et al.   Quantitative metabolite patterns of human brain tumors (Detection by 1H NMR spectroscopy in vivo and in vitro) . J Comput Assist Tomogr . 1994;18:705–713
  69. Furuya S , Naruse S , Ide M , et al.   Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method . NMR Biomed . 1997;10:25–30
  70. Shimizu H , Kumabe T , Tominaga T , et al.   Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy . Am J Neuroradiol . 1996;17:737–747
  71. Rijpkema M , Schuuring J , van der Meulen Y , et al.   Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging . NMR Biomed . 2003;16:12–18
  72. Barton SJ , Howe FA , Tomlins AM , et al.   Comparison of in vivo 1H MRS of human brain tumours with 1H HR-MAS spectroscopy of intact biopsy samples in vitro . MAGMA . 1999;8:121–128
  73. Lehnhardt FG , Rohn G , Ernestus RI , et al.   1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro (Malignancy-characteristic profiles of water soluble and lipophilic spectral components) . NMR Biomed . 2001;14:307–317
  74. Birken DL , Oldendorf WH . N-acetyl-L-aspartic acid (A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain) . Neurosci Biobehav Rev . 1989;13:23–31
  75. Miller BL . A review of chemical issues in 1H NMR spectroscopy (N-acetyl-L-aspartate, creatine and choline) . NMR Biomed . 1991;4:47–52
  76. Poptani H , Gupta RK , Roy R , et al.   Characterization of intracranial mass lesions with in vivo proton MR spectroscopy . AJNR Am J Neuroradiol . 1995;16:1593–1603
  77. Larsson HB , Christiansen P , Jensen M , et al.   Localized in vivo proton spectroscopy in the brain of patients with multiple sclerosis . Magn Reson Med . 1991;22:23–31
  78. Grossman RI , Lenkinski RE , Ramer KN , et al.   MR proton spectroscopy in multiple sclerosis . Am J Neuroradiol . 1992;13:1535–1543
  79. Husted CA , Goodin DS , Hugg JW , et al.   Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging . Ann Neurol . 1994;36:157–165
  80. Kwo-On-Yuen PF , Newmark RD , Budinger TF , et al.   Brain N-acetyl-L-aspartic acid in Alzheimer’s disease (A proton magnetic resonance spectroscopy study) . Brain Res . 1994;667:167–174
  81. Klunk WE , Panchalingam K , Moossy J , et al.   N-acetyl-L-aspartate and other amino acid metabolites in Alzheimer’s disease brain (A preliminary proton nuclear magnetic resonance study) . Neurology . 1992;42:1578–1585
  82. Chen JG , Charles HC , Barboriak DP , et al.   Magnetic resonance spectroscopy in Alzheimer’s disease (Focus on N-acetylaspartate) . Acta Neurol Scand . 2000;176(suppl):20–26
  83. Cheng LL , Ma MJ , Becerra L , et al.   Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy . Proc Natl Acad Sci USA . 1997;94:6408–6413
  84. Chan YL , Yeung DK , Leung SF , et al.   Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain . J Magn Reson Imaging . 1999;10:130–137
  85. Estève F , Rubin C , Grand S , et al.   Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy . Int J Radiat Oncol Biol Physics . 1998;40:279–286
  86. Oh J , Pelletier D , Henry R , et al.   Regional 1H MRSI, DTI and MTI Metrics Related to Clinical Disability in Multiple Sclerosis . Honolulu, HI: International Society for Magnetic Resonance Medicine; 2002;
  87. Star-Lack J , Spielman D , Adalsteinsson E , et al.   In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors . J Magn Reson . 1998;133:243–254
  88. Mangiardi JR . Biochemistry and metabolism of brain tumors . In:  Kaye AH ,  Laws ER editor. Brain Tumors (An Encyclopedic Approach) . New York, NY: Churchill Livingstone; 1995;p. 99–9112
  89. Gillies RJ , Raghunand N , Karczmar GS , et al.   MRI of the tumor microenvironment . J Magn Reson Imaging . 2002;16:430–450
  90. McKnight T , Love T , Lamborn K , et al.   Metabolic Profiles of Grade II Astrocytomas and Oligodendrogliomas Suggest Different Mechanisms of Energy Utilization . Toronto, Canada: ISMRM; 2003;
  91. Wilken B , Dechent P , Herms J , et al.   Quantitative proton magnetic resonance spectroscopy of focal brain lesions . Pediatr Neurol . 2000;23:22–31
  92. Tarnawski R , Sokol M , Pieniazek P , et al.   1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas . Int J Radiat Oncol Biol Phys . 2002;52:1271–1276
  93. Cho YD , Choi GH , Lee SP , et al.   (1)H-MRS metabolic patterns for distinguishing between meningiomas and other brain tumors . Magn Reson Imaging . 2003;21:663–672
  94. Murphy PS , Rowland IJ , Viviers L , et al.   Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? . Br J Radiol . 2003;76:459–463
  95. Barba I , Cabanas ME , Arus C . The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells . Cancer Res . 1999;59:1861–1868
  96. Griffin JL , Bollard M , Nicholson JK , et al.   Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy . NMR Biomed . 2002;15:375–384
  97. Brennan L , Hewage C , Malthouse JP , et al.   An NMR study of alterations in [1-13C]glucose metabolism in C6 glioma cells by gliotoxic amino acids . Neurochem Int . 2003;42:441–448
  98. Utriainen M , Komu M , Vuorinen V , et al.   Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS . J Neurooncol . 2003;62:329–338
  99. Cheng LL , Chang IW , Louis DN , et al.   Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens . Cancer Res . 1998;58:1825–1832
  100. Castillo M , Smith JK , Kwock L . Correlation of myo-inositol levels and grading of cerebral astrocytomas . Am J Neuroradiol . 2000;21:1645–1649
  101. Arnold DL , Shoubridge EA , Villemure JG , et al.   Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo (Preliminary observations on tumor grading) . NMR Biomed . 1990;3:184–189
  102. Bruhn H , Frahm J , Gyngell ML , et al.   Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo (Initial experience in patients with cerebral tumors) . Radiology . 1989;172:541–548
  103. Carapella CM , Carpinelli G , Knijn A , et al.   Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours . Acta Neurochir . 1997;68(suppl):127–132
  104. Carpinelli G , Carapella CM , Palombi L , et al.   Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors . Anticancer Res . 1996;16:1559–1563
  105. Rutter A , Hugenholtz H , Saunders JK , et al.   Classification of brain tumors by ex vivo 1H NMR spectroscopy . J Neurochem . 1995;64:1655–1661
  106. Fountas KN , Kapsalaki EZ , Gotsis SD , et al.   In vivo proton magnetic resonance spectroscopy of brain tumors . Stereotact Funct Neurosurg . 2000;74:83–94
  107. Underwood J , Tate AR , Luckin R , et al.   A prototype decision support system for MR spectroscopy-assisted diagnosis of brain tumours . Medinfo . 2001;10:561–565
  108. McKnight TR , von dem Bussche MH , Vigneron DB , et al.   Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence . J Neurosurg . 2002;97:794–802
  109. Sabatier J , Ibarrola D , Malet-Martino M , et al.   Brain tumors (Interest of magnetic resonance spectroscopy for the diagnosis and the prognosis) . Rev Neurol (Paris) . 2001;157:858–862
  110. Tate AR , Griffiths JR , Martinez-Perez I , et al.   Towards a method for automated classification of 1H MRS spectra from brain tumours . NMR Biomed . 1998;11:177–191
  111. Liang BC , Thornton AF , Sandler HM , et al.   Malignant astrocytomas (Focal tumor recurrence after focal external beam radiation therapy) . J Neurosurg . 1991;75:559–563
  112. Wallner KE , Galicich JH , Krol G , et al.   Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma . Int J Radiat Oncol Biol Phys . 1989;16:1405–1409
  113. Nakagawa K , Aoki Y , Fujimaki T , et al.   High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme . Int J Radiat Oncol Biol Phys . 1998;40:1141–1149
  114. Pirzkall A LD , McKnight TR , Graves E , et al.   MR-spectroscopy results in improved target-delineation for high-grade gliomas . Boston, MA: 42nd Annual Meeting of the American Society for Therapeutic Radiology and Oncology; 2000;
  115. Wald LL , Nelson SJ , Day MR , et al.   Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy . J Neurosurg . 1997;87:525–534
  116. Vigneron D , Bollen A , McDermott M , et al.   Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors . Magn Reson Imaging . 2001;19:89–8101
  117. Oppitz U , Maessen D , Zunterer H , et al.   3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation . Radiother Oncol . 1999;53:53–57
  118. Pirzkall A , Nelson SJ , McKnight TR , et al.   Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy . Int J Radiat Oncol Biol Phys . 2002;53:1254–1264
  119. Luyten PR , Marien AJ , Heindel W , et al.   Metabolic imaging of patients with intracranial tumors (H-1 MR spectroscopic imaging and PET) . Radiology . 1990;176:791–799
  120. Preul MC , Leblanc R , Caramanos Z , et al.   Magnetic resonance spectroscopy guided brain tumor resection (Differentiation between recurrent glioma and radiation change in two diagnostically difficult cases) . Can J Neurol Sci . 1998;25:13–22
  121. Kamada K , Houkin K , Abe H , et al.   Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy . Neurol Med Chir . 1997;37:250–256
  122. Rutkowski T , Tarnawski R , Sokol M , et al.   1H-MR spectroscopy of normal brain tissue before and after postoperative radiotherapy because of primary brain tumors . Int J Radiat Oncol Biol Phys . 2003;56:1381–1389
  123. Li X , Graves EE , Vigneron DB , et al.   Reliable Estimate of Lactate and Lipid for Newly-Diagnosed Gliomas Patients Using Lactate-Edited 3D 1H-MRSI With Ellipsoidal Space Sampling . Toronto, Canada: International Society for Magnetic Resonance Medicine; 2003;
  124. Graves E , Takahashi M , Pirzkall A , et al.   Serial 1H Magnetic Resonance Spectroscopic Imaging of Gliomas After Fractionated Radiation Therapy . Honolulu, HI: International Society of Magnetic Resonance Medicine; 2002;

 Supported by NCI K01 CA90244 and NCI P50 CA97297.

PII: S0093-7754(04)00325-2

doi: 10.1053/j.seminoncol.2004.07.003

Seminars in Oncology
Volume 31, Issue 5 , Pages 605-617 , October 2004

Article Tools

* Image Usage & Resolution